论文部分内容阅读
目的观察丁苯肽注射液治疗急性脑梗死患者的临床效果。方法选取医院因急性脑梗死入院治疗的患者56例,随机分为观察组和对照组,每组28例。对照组采取常规疗法,观察组在常规疗法基础上联合应用丁苯肽注射液治疗,观察2组用药后的临床效果,并客观对比NIHSS计分。结果观察组总有效率为96.43%,高于对照组的75.00%(P<0.05)。治疗前2组NIHSS计分比较差异无统计学意义(P>0.05);治疗后,观察组NIHSS计分优于对照组(P<0.05)。结论选择丁苯肽注射液对急性脑梗死患者进行救治疗效显著,有助于改善患者临床指征及NIHSS计分等指标,值得推广应用。
Objective To observe the clinical effect of buprenorphine injection in patients with acute cerebral infarction. Methods Fifty-six patients admitted to hospital for acute cerebral infarction were randomly divided into observation group and control group with 28 cases in each group. The control group was treated with conventional therapy. The observation group was treated with butanil injection on the basis of routine therapy. The clinical effects of the two groups were observed and compared objectively with NIHSS scores. Results The total effective rate in the observation group was 96.43%, which was higher than that in the control group (75.00%, P <0.05). There was no significant difference in NIHSS score between the two groups before treatment (P> 0.05). After treatment, the score of NIHSS in the observation group was better than that of the control group (P <0.05). CONCLUSION: The treatment of acute cerebral infarction with butanib injection is effective in improving the clinical indications and NIHSS score, which is worthy of popularization and application.